Correlation Between Cingulate Warrants and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and ProMIS Neurosciences, you can compare the effects of market volatilities on Cingulate Warrants and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and ProMIS Neurosciences.
Diversification Opportunities for Cingulate Warrants and ProMIS Neurosciences
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and ProMIS is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Cingulate Warrants and ProMIS Neurosciences
Assuming the 90 days horizon Cingulate Warrants is expected to generate 19.8 times more return on investment than ProMIS Neurosciences. However, Cingulate Warrants is 19.8 times more volatile than ProMIS Neurosciences. It trades about 0.14 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about 0.01 per unit of risk. If you would invest 12.00 in Cingulate Warrants on September 12, 2024 and sell it today you would lose (8.37) from holding Cingulate Warrants or give up 69.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 74.92% |
| Values | Daily Returns |
Cingulate Warrants vs. ProMIS Neurosciences
Performance |
| Timeline |
| Cingulate Warrants |
| ProMIS Neurosciences |
Cingulate Warrants and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and ProMIS Neurosciences
The main advantage of trading using opposite Cingulate Warrants and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| Cingulate Warrants vs. Equillium | Cingulate Warrants vs. DiaMedica Therapeutics | Cingulate Warrants vs. Valneva SE ADR | Cingulate Warrants vs. Vivani Medical |
| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world |